Qinghuai Zhang
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Colonoscopy compliance and diagnostic yield in a large population-based colorectal cancer screening programme.
Journal: International journal of colorectal disease
Published: September 04, 2023
Factors influencing advanced colorectal neoplasm anatomic site distribution in China: An epidemiological study based on colorectal cancer screening data.
Journal: Cancer medicine
Published: June 27, 2023
Derivation and validation of a nomogram incorporating modifiable lifestyle factors to predict development of colorectal adenomas after negative index colonoscopy.
Journal: Scientific reports
Published: June 11, 2023
The accuracy of the FIT in detecting advanced neoplasm is highest in young people aged 40 to 49 years: an analysis based on sex and age.
Journal: International journal of colorectal disease
Published: June 07, 2023
Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020.
Journal: BMC gastroenterology
Published: December 25, 2022
The comparison of risk factors for colorectal neoplasms at different anatomical sites.
Journal: International journal of colorectal disease
Published: December 23, 2022
Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: September 19, 2022
The prognostic and clinical value of p53 upregulated modulator of apoptosis expression in solid tumors: a meta-analysis and TCGA data review.
Journal: Expert review of molecular diagnostics
Published: September 16, 2022
A risk scoring system for advanced colorectal neoplasia in high-risk participants to improve current colorectal cancer screening in Tianjin, China.
Journal: BMC gastroenterology
Published: September 04, 2022
Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen.
Journal: Scientific reports
Published: August 23, 2022
Last Updated: 09/26/2026